Format

Send to

Choose Destination
See comment in PubMed Commons below
Ann Neurol. 2004 Mar;55(3):426-30.

Reduced striatal [123 I]FP-CIT binding in SCA2 patients without parkinsonism.

Author information

1
Biostructure and Bioimaging Institute, National Research Council, Via S. Pansini 5, 80131 Naples, Italy. andrea.varrone@ibb.cnr.it

Abstract

Degeneration of substantia nigra has been described in spinocerebellar ataxia type 2 (SCA2). In this study, dopamine transporter (DAT) density with [123 I]FP-CIT SPECT was studied in six SCA2 patients with no parkinsonian signs, six Parkinson's disease (PD) patients, and six controls. Marked striatal DAT loss was found in both SCA2 and PD patients. However, a more severe reduction in the caudate and a higher putamen to caudate ratio distinguished SCA2 from PD patients, suggesting a more uniform nigrostriatal impairment in SCA2. Striatal DAT density of SCA2 patients correlated with the severity of cerebellar ataxia.

PMID:
14991822
DOI:
10.1002/ana.20054
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Wiley
    Loading ...
    Support Center